This is the story about Steve Sjöquist - writer, HIV activist and deacon at Karolinska Universitetssjukhuset in Stockholm. Steve was diagnosed with HIV in 1987 and he was one of the first Swedish AIDS patients to get the new antiretroviral therapy in 1996. It saved his life.

This is a pre-version of the documentary about the writer and AIDS activist, Steve Sjöquist, who was diagnosed with HIV in 1987. Steve was one of the first Swedish AIDS patients to get the new ARV medication in 1996, and it saved his life.

XIX International AIDS Conference. Session on Pediatrics with medical doctors and scientists discussing prevention of mother-to-child transmission and the development of antiretroviral treatments suitable for infants and small children.

Cutaways of booths at the XVIII International AIDS Conference in Vienna in 2010.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Dr Daria Hazuda from MSD, who has been involved in antiretroviral drug development during the past 20 years, holds a presentation. She is also interviewed about leadership and the progress of ARV and vaccine development.

Daria Hazuda from MSD explains the virology of HIV and talks about the past clinical studies on ARV, in particular integrase inhibitors, which she has been involved in. She also reflects on HIV as an exceptional virus and how to influence a new generation of HIV researchers.

XVI International AIDS Conference in Toronto. Panel session on health policy with Swedish AIDS Ambassador Lennart Hjelmåker, UNAIDS Executive Director Peter Piot, Indian Minister of Health Anbunmani Romdass, Sipho Mthathi from TAC and Jeffrey Sturchio from Merck.